105
Participants
Start Date
January 31, 2020
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2031
e-PRO Intervention
"Statements of symptoms and patients' health status (PROs) will be collected via a web interface, including access and use in patients with burden symptoms.~The platform will include four items concerning 7 side effects of fibrosis of grade \> 2 in breast cancer. Patients will be encouraged to evaluate on a 5-point Likert scale the frequency, the intensity and the repercussions on the daily life of some symptoms during the last 7 days, in particular on:~* general pain~* anxiety~* sadness~* texture of the treated breast~* Patients will also be invited to express themselves on the severity of two other symptoms of their choice, to their worst degree, by listing and rating them on a 5-point scale ranging from None to Very severe Finally, the aesthetic impact will be evaluated by patients on a visual analogue scale (VAS) of 0 to 100mm"
Pravastatin
All patients will take Pravastatin 40 mg per day (From Day 0 to Month 12).
RECRUITING
ICM Val d'Aurelle, Montpellier
Institut du Cancer de Montpellier - Val d'Aurelle
OTHER